Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Bupredermal TM

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.

Active ingredients: buprenorphine

Brand name

(ARTG)

: BUPREDERMAL buprenorphine 30 micrograms/hour transdermal drug delivery system sachet

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

What this medicine is used for

(ARTG)

BUPREDERMAL patches are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. BUPREDERMAL patches are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. BUPREDERMAL patches are not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

  • Drug delivery system, transdermal
  • Transdermal
  • Beige coloured rectangular patch with rounded corners on an aluminised rigid removable protective layer. The trade name and the strength is printed on the patch.

Storage conditions

(ARTG)

  • Store below 25 degrees Celsius
  • Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

  • 2 patches pack
  • 4 patches pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient buprenorphine

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Queensland Government logo Government of South Australia, health department logo Tasmanian government logo Victorian government logo Government of Western Australia, health department logo

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.

© 2024 Healthdirect Australia Limited